Correlation Between 4D Molecular and CannBioRx Life

Can any of the company-specific risk be diversified away by investing in both 4D Molecular and CannBioRx Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and CannBioRx Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 4D Molecular Therapeutics and CannBioRx Life Sciences, you can compare the effects of market volatilities on 4D Molecular and CannBioRx Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of CannBioRx Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and CannBioRx Life.

Diversification Opportunities for 4D Molecular and CannBioRx Life

0.59

Correlation Coefficient

4D Molecular  CannBioRx Life

Very weak diversification

The 3 months correlation between FDMT and CannBioRx is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and CannBioRx Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CannBioRx Life Sciences and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with CannBioRx Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CannBioRx Life Sciences has no effect on the direction of 4D Molecular i.e., 4D Molecular and CannBioRx Life go up and down completely randomly.

Pair Corralation between 4D Molecular and CannBioRx Life

Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the CannBioRx Life. But the stock apears to be less risky and, when comparing its historical volatility, 4D Molecular Therapeutics is 2.92 times less risky than CannBioRx Life. The stock trades about -0.09 of its potential returns per unit of risk. The CannBioRx Life Sciences is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.95  in CannBioRx Life Sciences on December 29, 2024 and sell it today you would lose (0.19) from holding CannBioRx Life Sciences or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.39%
Values	Daily Returns

4D Molecular Therapeutics  vs.  CannBioRx Life Sciences

4D Molecular Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days 4D Molecular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

CannBioRx Life Sciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in CannBioRx Life Sciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, CannBioRx Life showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with 4D Molecular and CannBioRx Life

The main advantage of trading using opposite 4D Molecular and CannBioRx Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, CannBioRx Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CannBioRx Life will offset losses from the drop in CannBioRx Life's long position.

The idea behind 4D Molecular Therapeutics and CannBioRx Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.